The MAT recommends the State of NM work with Gilead, the manufacturer of Remdesivir to obtain approval for University of NM Hospital and Presbyterian to participate in clinical trials for COVID-19

The MAT recommends the State of NM work with Gilead, the manufacturer of Remdesivir to obtain approval for University of NM Hospital and Presbyterian to participate in clinical trials for COVID-19; however, availability of Remdesivir is very limited and therefore...